IGHG3 and familial dilated cardiomyopathy: Furthermore, in patients with DCM, IA on a protein-A column, when performed in conjunction with an improved treatment regimen for IgG3 elimination, was found superior to the sole use of that protein-A column-based conventional IA, in terms of both LVEF and CI improvement [107].